| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |